Polyherbal formulation Anoac‑H suppresses the expression of RANTES and VEGF for the management of bleeding hemorrhoids and fistula

Porwal,Ashwin; Kundu,Gopal C.; Bhagwat,Gajanan; Butti,Ramesh

doi:10.3892/mmr.2021.12376

Polyherbal formulation Anoac‑H suppresses the expression of RANTES and VEGF for the management of bleeding hemorrhoids and fistula

Authors:
- Ashwin Porwal
- Gopal C. Kundu
- Gajanan Bhagwat
- Ramesh Butti
View Affiliations

Affiliations: Healing Hands Clinic, Pune, Maharashtra 411001, India, Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Centre for Cell Science, Pune, Maharashtra 411007, India, Healing Hands & Herbs (R&D Center), Pune, Maharashtra 411002, India
Published online on: August 16, 2021 https://doi.org/10.3892/mmr.2021.12376
Article Number: 736
Copyright: © Porwal et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hemorrhoids and fistula are considered the most common anorectal conditions in the general population. These conditions affect the quality of a patient's life by causing pain and bleeding during defecation or even in the resting state. Lower grades of hemorrhoids may be controlled by traditional measures. However, surgery is an effective treatment option in recurrent‑lower and higher‑grade hemorrhoids. Surgical procedures are associated with various complications, including pain and delayed wound healing. Recurrence of hemorrhoids is also a major concern in the post‑operative period. An anal fistula is the connection between the anus and the skin and causes severe pain, swelling, as well as blood and pus discharge. Fistula has serious social and economic consequences. Hence, it is important to understand the pathophysiology and molecular pathology of hemorrhoids and fistula, to identify the molecular targets and to develop pharmacological‑interventions. In a previous study by our group, the polyherbal formulation Anoac‑H was developed for the treatment of different stages of hemorrhoids and fistula, and it was demonstrated that Anoac‑H is an effective formulation for treating hemorrhoids. However, the molecular mode of action of Anoac‑H on hemorrhoids and fistula had remained elusive. In the present study, it was determined that this formulation reduces the migration of mesenchymal (fibroblasts) and immune (RAW 264.7) cells without affecting their viability. It was also observed that Anoac‑H suppresses the expression of regulated upon activation, normal T cell expressed and presumably secreted (RANTES) and VEGF in fibroblasts and macrophages. Inflammation and elevated expression of RANTES and VEGF were observed in hemorrhoids and fistula. However, inflammation, as well as the expression of RANTES and VEGF, were significantly reduced in treated human hemorrhoid and fistula tissues as compared to untreated ones, confirming the in vitro results.

View Figures

View References

1	Foxx-Orenstein AE, Umar SB and Crowell MD: Common anorectal disorders. Gastroenterol Hepatol (NY). 10:294–301. 2014.PubMed/NCBI
2	Guindic LC: Treatment of uncomplicated hemorrhoids with a Hemor-Rite^® cryotherapy device: A randomized, prospective, comparative study. J Pain Res. 7:57–63. 2014.PubMed/NCBI
3	Lorenzo-Rivero S: Hemorrhoids: Diagnosis and current management. Am Surg. 75:635–642. 2009. View Article : Google Scholar : PubMed/NCBI
4	Sun Z and Migaly J: Review of hemorrhoid disease: Presentation and management. Clin Colon Rectal Surg. 29:22–29. 2016. View Article : Google Scholar : PubMed/NCBI
5	Riss S, Weiser FA, Riss T, Schwameis K, Mittlböck M and Stift A: Haemorrhoids and quality of life. Colorectal Dis. 13:e48–e52. 2011. View Article : Google Scholar : PubMed/NCBI
6	Peery AF, Sandler RS, Galanko JA, Bresalier RS, Figueiredo JC, Ahnen DJ, Barry EL and Baron JA: Risk factors for hemorrhoids on screening colonoscopy. PLoS One. 10:e01391002015. View Article : Google Scholar : PubMed/NCBI
7	Lohsiriwat V: Hemorrhoids: From basic pathophysiology to clinical management. World J Gastroenterol. 18:2009–2017. 2012. View Article : Google Scholar : PubMed/NCBI
8	Shrivastava L, da Silva Borges G and Shrivastava R: Clinical efficacy of a dual action, topical anti-edematous and antiinflammatory device for the treatment of external hemorrhoids. Clin Exp Pharmacol. 8:1–7. 2018. View Article : Google Scholar
9	Srivastava A, Yadav SK, Yachha SK, Thomas MA, Saraswat VA and Gupta RK: Pro-inflammatory cytokines are raised in extrahepatic portal venous obstruction, with minimal hepatic encephalopathy. J Gastroenterol Hepatol. 26:979–986. 2011. View Article : Google Scholar : PubMed/NCBI
10	Wojdasiewicz P, Poniatowski ŁA and Szukiewicz D: The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014:5614592014. View Article : Google Scholar : PubMed/NCBI
11	Gulati K, Guhathakurta S, Joshi J, Rai N and Ray AJ: Cytokines and their role in health and disease: A brief overview. MOJ Immunol. 4:1–9. 2016.
12	Schall TJ: Biology of the RANTES/SIS cytokine family. Cytokine. 3:165–183. 1991. View Article : Google Scholar : PubMed/NCBI
13	Appay V, Brown A, Cribbes S, Randle E and Czaplewski LG: Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutants. J Biol Chem. 274:27505–27512. 1999. View Article : Google Scholar : PubMed/NCBI
14	Nottingham JM and Rentea RM: Anal Fistulotomy (Seton Placement). StatPearls Publishing; Treasure Island, FL: 2020
15	Gardner IH, Siddharthan RV and Tsikitis VL: Benign anorectal disease: Hemorrhoids, fissures, and fistulas. Ann Gastroenterol. 33:9–18. 2020.PubMed/NCBI
16	Haddow JB, Musbahi O, MacDonald TT and Knowles CH: Comparison of cytokine and phosphoprotein profiles in idiopathic and Crohn's disease-related perianal fistula. World J Gastrointest Pathophysiol. 10:42–53. 2019. View Article : Google Scholar : PubMed/NCBI
17	Wang K, Deng P, Sun Y, Ye P, Zhang A, Wu C, Yue Z, Chen Z and Xia J: MicroRNA-155 promotes neointimal hyperplasia through smooth muscle-like cell-derived RANTES in arteriovenous fistulas. J Vasc Surg. 67:933–944.e3. 2018. View Article : Google Scholar : PubMed/NCBI
18	Sheikh P and Baakza A: Management of fistula-in-ano-the current evidence. Indian J Surg. 76:482–486. 2014. View Article : Google Scholar : PubMed/NCBI
19	Emile SH: Recurrent anal fistulas: When, why, and how to manage? World J Clin Cases. 8:1586–1591. 2020. View Article : Google Scholar : PubMed/NCBI
20	Azeemuddin M, Viswanatha GL, Rafiq M, Thippeswamy AH, Baig MR, Kavya KJ, Patki PS and Shyam R: An improved experimental model of hemorrhoids in rats: Evaluation of antihemorrhoidal activity of an herbal formulation. ISRN Pharmacol. 2014:5309312014. View Article : Google Scholar : PubMed/NCBI
21	Barnhoorn MC, Hakuno SK, Bruckner RS, Rogler G, Hawinkels LJAC and Scharl M: Stromal cells in the pathogenesis of inflammatory bowel disease. J Crohns Colitis. 14:995–1009. 2020. View Article : Google Scholar : PubMed/NCBI
22	van Onkelen RS, Gosselink MP, van Meurs M, Melief MJ, Schouten WR and Laman JD: Pro-inflammatory cytokines in cryptoglandular anal fistulas. Tech Coloproctol. 20:619–625. 2016. View Article : Google Scholar : PubMed/NCBI
23	Rakinic J and Poola VP: Hemorrhoids and fistulas: New solutions to old problems. Curr Probl Surg. 51:98–137. 2014. View Article : Google Scholar : PubMed/NCBI
24	Hashempur MH, Khademi F, Rahmanifard M and Zarshenas MM: An evidence-based study on medicinal plants for hemorrhoids in medieval Persia. J Evid Based Complementary Altern Med. 22:969–981. 2017. View Article : Google Scholar : PubMed/NCBI
25	Porwal A, Gandhi P and Kulkarni D: A prospective, open-label, single arm, single center study to evaluate safety and efficacy of ANOAC-H tablet in the treatment of bleeding hemorrhoids grades 1–3. Int J Ayurveda. 2018.
26	Kumar D, Haldar S, Gorain M, Kumar S, Mulani FA, Yadav AS, Miele L, Thulasiram HV and Kundu GC: Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway. BMC Cancer. 18:522018. View Article : Google Scholar : PubMed/NCBI
27	Leopold JA, Walker J, Scribner AW, Voetsch B, Zhang YY, Loscalzo AJ, Stanton RC and Loscalzo J: Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J Biol Chem. 278:32100–32106. 2003. View Article : Google Scholar : PubMed/NCBI
28	Butti R, Nimma R, Kundu G, Bulbule A, Kumar TV, Gunasekaran VP, Tomar D, Kumar D, Mane A, Gill SS, et al: Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression. Oncogene. 40:2002–2017. 2021. View Article : Google Scholar : PubMed/NCBI
29	Kumar D, Kumar S, Gorain M, Tomar D, Patil HS, Radharani NN, Kumar TV, Patil TV, Thulasiram HV and Kundu GC: Notch1-MAPK signaling axis regulates CD133⁺ cancer stem cell-mediated melanoma growth and angiogenesis. J Invest Dermatol. 136:2462–2474. 2016. View Article : Google Scholar : PubMed/NCBI
30	Tse GN: Practical management of hemorrhoids: Pitfalls and plain sailing. Can Fam Physician. 34:655–659. 1988.PubMed/NCBI
31	Scharl M and Rogler G: Pathophysiology of fistula formation in Crohn's disease. World J Gastrointest Pathophysiol. 5:205–212. 2014. View Article : Google Scholar : PubMed/NCBI
32	Pata F, Sgró A, Ferrara F, Vigorita V, Gallo G and Pellino G: Anatomy, physiology and pathophysiology of haemorrhoids. Rev Recent Clin Trials. 16:75–80. 2021. View Article : Google Scholar : PubMed/NCBI
33	Mott T, Latimer K and Edwards C: Hemorrhoids: Diagnosis and treatment options. Am Fam Physician. 97:172–179. 2018.PubMed/NCBI
34	Lohsiriwat V: Treatment of hemorrhoids: A coloproctologist's view. World J Gastroenterol. 21:9245–9252. 2015. View Article : Google Scholar : PubMed/NCBI
35	Moggia E, Talamo G, Gallo G, Bianco A, Barattini M, Salsano G, Zefiro D, Stefanini T and Berti S: Do we have another option to treat bleeding hemorrhoids? The Emborrhoid technique: Experience in 16 patients. Rev Recent Clin Trials. 16:81–86. 2021. View Article : Google Scholar : PubMed/NCBI
36	Lu M, Shi GY, Wang GQ, Wu Y, Liu Y and Wen H: Milligan-Morgan hemorrhoidectomy with anal cushion suspension and partial internal sphincter resection for circumferential mixed hemorrhoids. World J Gastroenterol. 19:5011–5015. 2013. View Article : Google Scholar : PubMed/NCBI
37	Nienhuijs S and de Hingh I: Conventional versus LigaSure hemorrhoidectomy for patients with symptomatic Hemorrhoids. Cochrane Database Syst Rev. Jan 21–2009.(Epub ahead of print). doi: 10.1002/14651858.CD006761.pub2. View Article : Google Scholar : PubMed/NCBI
38	Patti R, Almasio PL, Muggeo VM, Buscemi S, Arcara M, Matranga S and Di Vita G: Improvement of wound healing after hemorrhoidectomy: A double-blind, randomized study of botulinum toxin injection. Dis Colon Rectum. 48:2173–2179. 2005. View Article : Google Scholar : PubMed/NCBI
39	Khan KI, Waqas A, Akmal M, Mahmood S and Iqbal A: Efficacy of combination of 0.2% GTN and lignocaine ointments in wound healing and pain relief after Milligan Morgan hemorrhoidectomy-a comparison with lignocaine and 0.2% GTN ointments separately. Int J Surg. 12:329–333. 2014. View Article : Google Scholar : PubMed/NCBI
40	Giannini I, Pecorella G, Pennisi D, Santangelo G, Digennaro R, Latorre F, Giuliani G and Altomare DF: Control of post-hemorrhoidectomy symptoms and wound healing by Triclosan: A randomized, double-blind, controlled trial. Minerva Chir. 69:75–82. 2014.PubMed/NCBI
41	Gallo G, Mistrangelo M, Passera R, Testa V, Pozzo M, Perinotti R, Lanati I, Lazzari I, Tonello P, Ugliono E, et al: Efficacy of mesoglycan in pain control after excisional hemorrhoidectomy: A pilot comparative prospective multicenter study. Gastroenterol Res Pract. 2018:64238952018. View Article : Google Scholar : PubMed/NCBI
42	Sturiale A, Gallo G, Brusciano L, Cacace C, Cafaro D, Celedon Porzio F and Naldini G: Safety and efficacy of proctosoll allevia in the management of haemorrhoidal disease in adults: A prospective randomized clinical trial. Rev Recent Clin Trials. 15:152–159. 2020. View Article : Google Scholar : PubMed/NCBI
43	Derakhshan AR: Natural treatments for fissure in ano used by traditional Persian scholars, Razi (Rhazes) and Ibn Sina (Avicenna). J Evid Based Complementary Altern Med. 22:324–333. 2017. View Article : Google Scholar : PubMed/NCBI
44	Mistry S, Patidar R, Vyas V, Jena J and Dutt KR: Anti-inflammatory activity of Mimosa Pudica Linn. (Mimosaceae) leaves: An ethnpharmacological study. Int J Pharm Sci Res. 4:17892012.
45	Xia M, Liu L, Qiu R, Li M, Huang W, Ren G and Zhang J: Anti-inflammatory and anxiolytic activities of Euphorbia hirta extract in neonatal asthmatic rats. AMB Express. 8:1792018. View Article : Google Scholar : PubMed/NCBI
46	Murthuza S and Manjunatha BK: In vitro and in vivo evaluation of anti-inflammatory potency of Mesua ferrea, Saraca asoca, Viscum album and Anthocephalus cadamba in murine macrophages raw 264.7 cell lines and wistar albino rats. Beni-Seuf Univ J Appl Sci. 7:719–723. 2018.
47	Nimisha, Rizvi DA, Fatima Z, Neema and Kaur CD: Antipsoriatic and anti-inflammatory studies of Berberis aristata extract loaded nanovesicular gels. Pharmacogn Mag. 13 (Suppl 3):S587–S594. 2017. View Article : Google Scholar : PubMed/NCBI